S.2384

Prohibits the state, participating ERISA, or any health plan from purchasing referenced drugs for a cost higher than the referenced rate.

Introduced·1/30/26
Introduced Text

Rhode Island S2384 aims to protect residents from excessive prescription drug prices by setting a maximum fair price and penalizing non-compliance.

Rhode Island S2384 establishes a maximum fair price for prescription drugs to protect residents from excessive costs. The bill prohibits the state, participating ERISA plans, and health plans from purchasing drugs at a cost higher than this maximum fair price. It also mandates that savings from adhering to this price cap be used to reduce costs for consumers. The bill includes penalties for manufacturers who fail to negotiate in good faith or withdraw drugs to avoid price limitations. The insurance commissioner is tasked with enforcing these provisions and assessing penalties.

Included in complete analysis

  • Overview
  • Core Provisions
  • Implementation
  • Impact
  • Legal Framework
  • Critical Issues

See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.

Where it stands

Current
Health and Human Services Committee
Next
Session adjourned — paused until it reconvenes

Sponsors

DDDDDDDD
8
0
Democratic CaucusRepublican Caucus

Roll Call Votes

Senate Committee on Health & Human Services: Be held for further study

8 Yea

DDRDDDDD

0 Nay

1 Absent

R

Calendar

Mar 26

12:00 AM

Senate Health and Human Services Hearing

History

Mar 26

Senate

Committee recommended measure be held for further study

Mar 20

Senate

Scheduled for hearing and/or consideration (03/26/2026)

Jan 30

Senate

Introduced, referred to Senate Health and Human Services